Fisher And Paykel Healthcare Corpo dividend and valuation

FPH · ASX · AUD

Compare Fisher And Paykel Healthcare Corpo
$40.42Change from previous close: −0.47%Absolute change: −$0.19

Close · November 20, 2026

Valuation

Fisher And Paykel Healthcare Corpo paid $0.44 per share in dividends over the last 12 months (yield 1.1%). Last ex-dividend date: June 22, 2026. The P/E ratio is 57.7. The average price target of 8 analysts is $39.51.

Data as of November 22, 2026

Fisher And Paykel Healthcare Corpo compared with similar companies

Fisher And Paykel Healthcare Corpo's P/E (trailing 12 months): 57.7, +38% against the median of a group of 10 similar companies (41.9).

Fisher And Paykel Healthcare Corpo's metrics compared with similar companies
MetricFisher And Paykel Healthcare CorpoMedian25th–75th percentileBand
P/E (trailing 12 months)57.741.923.5 – 67.6Middle
Forward P/E45.618.815.4 – 33.8High
EV/EBITDA30.818.615.4 – 22.4High
Price/book13.85.712.31 – 7.74High
Price/sales10.34.222.83 – 8.11High
Gross margin63.7%61.8%49.6% – 66.2%Middle
Operating margin27.6%17.8%11.7% – 26.7%High
Net margin20.3%10.6%6.7% – 17.1%High
ROE23.4%10.5%7.3% – 21.8%High
Debt/equity0.070.370.16 – 1.02Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$23.78B
Enterprise value
$23.41B
PEG
43.6
EV/revenue
10.1

Profitability and growth

ROA
14.7%
ROIC
18.5%
Revenue growth (year over year)
14.0%
Earnings growth (year over year)
14.3%

Financial health

Total cash
$461.1M
Total debt
$146.1M
Current ratio
2.32
Quick ratio
1.62

Dividends

Annual dividend per share
$0.44
Dividend yield
1.1%
Payout ratio
54.2%
Ex-dividend date
June 22, 2026

Analysts and estimates

Average price target
$39.51
Median price target
$40.00
High price target
$47.32
Low price target
$26.20
Analysts with a price target
8
Forward EPS
$0.89
EPS estimate, current year
$0.94

Shares and trading

Beta
0.93
Average volume
478.21K
Shares outstanding
588.27M
Float
584.75M
Institutional ownership
38.9%
Insider ownership
3.7%